Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Apr 30, 2024

BUY
$26.74 - $40.81 $909 - $1,387
34 New
34 $0
Q3 2023

Oct 25, 2023

SELL
$26.74 - $40.81 $615 - $938
-23 Reduced 40.35%
34 $0
Q4 2022

Jan 27, 2023

BUY
$29.23 - $40.28 $1,666 - $2,295
57 New
57 $1,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $609M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Concord Wealth Partners Portfolio

Follow Concord Wealth Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concord Wealth Partners, based on Form 13F filings with the SEC.

News

Stay updated on Concord Wealth Partners with notifications on news.